Medcompare - The Buyer's Guide for Medical Professionals Ophthalmology Buyer's Guide
Products New Products News Videos Journal Updates Articles Resources Events CME/CE
Search Medcompare
Enter Keyword(s):


Advertisement
Articles
The Value of the Ocular Response Analyzer (ORA) in the Assessment of Ectasia Risk in LASIK Patients
The Value of the Ocular Response Analyzer (ORA) in the Assessment of Ectasia Risk in LASIK Patients
Advertisement
> > > GDx™ Scanning Laser Polarimetry

GDx™ Scanning Laser Polarimetry

GDx™ Scanning Laser Polarimetry
General Information
VendorCarl Zeiss Meditec, Inc.
ItemGDx™ Scanning Laser Polarimetry
Features
  • Clinically proven: GDx analysis has been proven to accurately discriminate between healthy and glaucomatous eyes and to be predictive of visual field loss.
  • Provides unique early case detection: The GDx is the only glaucoma imaging device with a separate Screening Mode to help you identify which patients should receive a full glaucoma examination.
  • Tracks change over time: The Advanced Serial Analysis feature helps you to evaluate subtle RNFL changes so you can manage glaucoma with more confidence.
  • Simple: GDx examinations are easy for your patients and staff.
  • Reports are clear and intuitive.
  • Portable: Move your GDx between offices with an optional hard or soft carrying case.
  • Fast: Typical exam time ranges from 1 to 3 minutes.
ApprovalUSA
FixationExterior target
Illumination SourceGaAIAs laser diode, 780 nm
Measurement Area15 x 15 degrees
Ametropia Correction-10 diopters to +10 diopters
Acquisition time0.7 seconds
PricingRequest Quote     
Product Description
The GDx provides highly reproducible, objective measurements of the RNFL, to detect structural changes early. It then compares these measurements to an age-stratified, multi-ethnic normative database, providing you with a unique visual representation. It also uses neural network techniques to calculate a unique Nerve Fiber Index (NFI) to determine the likelihood of glaucoma. A recent study found that the NFI can differentiate between normal eyes and glaucomatous eyes before visual field loss with sensitivity and specificity of 83% and 82%, respectively.
Go to Vendor Product Page
Go to Vendor Website
View Vendor Contact Information
NOTE: Medcompare disclaims any information on this site. The information found on Medcompare (Drug Guide, Product Listings and otherwise) is intended for use by medical professionals. This information is not intended to replace the information, advice or instructions from a medical doctor. Pricing information is approximate, actual prices may vary.